- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
ABC
VIE
Week ended 07 Aug 2026
Weekly Investor Report
Cencora, Inc. · Healthcare · Medical Distribution
Latest close
279.9 EUR
3.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 3.3% above the Trend Line and sits at 57.5% of its 52-week range. The latest completed week returned 3.6%, after a 5.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
56
out of 100
Latest Close
279.9 EUR
7 Aug 2026
1W Return
3.6%
latest completed week
4W Return
5.6%
short-term follow-through
12W Return
25.1%
quarterly tape
Trend Breadth
63.5%
33 of 52 weeks active
Volume Ratio
9.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.6%
Latest completed week; four-week move 5.6%.
Indicator stack
35/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 3.3% above the Trend Line and sits at 57.5% of its 52-week range. The latest completed week returned 3.6%, after a 5.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 9.1x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 5.6% over four weeks, 25.1% over 12 weeks, and 17.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year33
Trend breadth63.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change685.0%Four-week change in activity pressure.
Leadership-17.47Latest relative-leadership reading.
RS change17.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-14.9%Distance below the 52-week high.
13-week volatility2.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+7.4%Week of 26 Jun.
Worst week-12.7%Week of 8 May.
Latest week+3.6%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains9
Flat weeks0
Modest losses10
Sharp losses4
Recent vol2.8%13-week weekly-return volatility.
Base vol3.8%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.1% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAT Healthcare
4-week rank32 / 100
Group average2.6%
Trend breadth47.0%
Trend47.0%active weekly trend signals
MD73.0%positive activity pressure
RS10.0%positive relative leadership
Four-week leaders
IndustryAT Medical Distribution
4-week rank2 / 5
Group average1.5%
Trend breadth20.0%
Trend20.0%active weekly trend signals
MD80.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis19/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.18; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Earnings Flash (COR) Cencora, Inc. Posts Q2 Adjusted EPS $4.75 per Share, vs. FactSet Est of $4.82 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 279.9 EUR | 3.6% | 271.1 EUR | 234.1 EUR | 0.79 | -17.47 | 80 | Off |
| 31 Jul 2026 | 270.2 EUR | -0.5% | 271.3 EUR | 233.4 EUR | 0.66 | -18.19 | 15 | Off |
| 24 Jul 2026 | 271.6 EUR | -0.6% | 271.9 EUR | 232.7 EUR | 0.52 | -18.16 | 0 | Off |
| 17 Jul 2026 | 273.3 EUR | 3.1% | 272.4 EUR | 232.0 EUR | 0.33 | -16.84 | 0 | Off |
| 10 Jul 2026 | 265.1 EUR | 2.3% | 273.0 EUR | 231.4 EUR | -0.14 | -21.20 | 19 | Off |
| 3 Jul 2026 | 259.2 EUR | 1.9% | 274.0 EUR | 230.7 EUR | -0.57 | -24.33 | 0 | Off |
| 26 Jun 2026 | 254.3 EUR | 7.4% | 275.0 EUR | 230.2 EUR | -0.95 | -24.38 | 0 | Off |
| 19 Jun 2026 | 236.8 EUR | -2.1% | 277.1 EUR | 229.6 EUR | -1.24 | -31.34 | 0 | Off |
| 12 Jun 2026 | 242.0 EUR | 1.0% | 279.8 EUR | 229.2 EUR | -1.26 | -27.41 | 0 | Off |
| 5 Jun 2026 | 239.7 EUR | 4.3% | 282.3 EUR | 228.7 EUR | -1.30 | -26.56 | 0 | Off |
| 29 May 2026 | 229.9 EUR | -2.4% | 284.7 EUR | 228.2 EUR | -1.22 | -30.72 | 0 | Off |
| 22 May 2026 | 235.6 EUR | 5.3% | 286.7 EUR | 227.7 EUR | -1.22 | -27.55 | 0 | Off |
| 15 May 2026 | 223.7 EUR | -0.5% | 288.4 EUR | 227.2 EUR | -1.22 | -30.23 | 0 | Off |
| 8 May 2026 | 224.9 EUR | -12.7% | 290.1 EUR | 226.8 EUR | -1.20 | -30.62 | 108 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.